Detalhe da pesquisa
1.
The patterns and risk factors of relapse in oesophageal squamous cell cancers who achieve pathologic complete response to neoadjuvant chemoradiotherapy.
Eur J Cardiothorac Surg
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38810125
2.
Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis.
Hum Vaccin Immunother
; 20(1): 2318815, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38419524
3.
Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node-positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
Cancer Med
; 12(4): 4077-4086, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36134648
4.
BCL6-SPECC1L: A Novel Fusion Gene in Nasopharyngeal Carcinoma.
Technol Cancer Res Treat
; 21: 15330338221139981, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36412101
5.
Development and Validation of Survival Nomograms in Patients with Primary Bladder Lymphoma.
J Clin Med
; 11(11)2022 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35683570
6.
Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer.
JCI Insight
; 7(16)2022 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35993362
7.
Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma.
EBioMedicine
; 86: 104371, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434949
8.
Prognostic impact of sterilized lymph nodes in esophageal squamous cell carcinomas after neoadjuvant chemoradiotherapy.
Eur J Surg Oncol
; 47(12): 3074-3080, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023168
9.
Integration of Tumor Heterogeneity for Recurrence Prediction in Patients with Esophageal Squamous Cell Cancer.
Cancers (Basel)
; 13(23)2021 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885197
10.
Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.
EMBO Mol Med
; 12(9): e12050, 2020 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32657028
11.
Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma.
Cancer Med
; 8(10): 4633-4643, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268626